Background Research
In brief
DeepValues Research published “Background Research” on AT&T (T) on Feb 19, 2026. Palantir sells enterprise software (data analytics/AI platforms) under two main licensing models - cloud-based (Palantir Cloud/Apollo) and on-premises (Foundry/Gotham) subscriptions - plus related professional services.
Source: https://research.deepvalues.ai/company/t/palantir/ · Markdown · More on AT&T (T)
Contents
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. All figures are in USD.
Business Model#
Palantir sells enterprise software (data analytics/AI platforms) under two main licensing models - cloud-based (Palantir Cloud/Apollo) and on-premises (Foundry/Gotham) subscriptions - plus related professional services. In 2024 government contracts accounted for ~55% of revenue and commercial deals ~45% . The company's products (Foundry for industry, Gotham for government) target large organizations needing custom data integration and AI. Palantir reports 711 total customers as of end-2024 . Its revenue sources are roughly divided among Cloud subscriptions, On-Premises software, and implementation services (though exact splits aren't published, analysts note subscription sales dominate). (See chart below for relative pricing multiples versus share price.)
-
Customers: 711 global customers (2024-end) across ~90 industries, up from 497 in 2023 . Key clients include government agencies (U.S. DoD, CDC, etc.) and commercial firms (Airbus, BP, etc.).
-
Units sold: Palantir does not report "units"; licensing is typically enterprise-scale deals. Instead, it reports "monthly active subscriptions" and deal counts. For example, in 2023 it introduced "AIP Bootcamps" to initiate ~915 new prospects and closed 136 new U.S. commercial deals in Q1 2024.
Figure: Palantir annual stock price (blue) vs. price-to-book ratio (orange), showing the surge in 2024 after years of low prices (source: historical data ).
Headwinds and Risks#
Palantir's growth is exposed to macro and political factors. Its 10-K explicitly warns that economic downturns or tech spending cuts could hurt demand . High inflation, rising interest rates or recessions may force customers (especially governments) to delay or cut contracts . Geopolitical instability (e.g. U.S./China tensions, war in Ukraine) and shifting government budgets (e.g. defense or intelligence cuts) pose risks to the sizable public-sector business. Industry headwinds include fierce competition from large cloud/AI providers (AWS, Microsoft, Google) which also offer analytics platforms. Regulatory/policy risks include data privacy laws, export controls, and public scrutiny of Palantir's government work. Analysts note Palantir's heavy U.S. government reliance means "federal spending disruptions" could significantly impact revenue. In summary, short- and long-term risks center on macroeconomic cycles, policy/regulatory changes, customer budget cuts, and competitive pressures .
Cost Structure#
Palantir's revenue is high-margin but its operating model is labor-intensive. Key costs are:
-
R&D and Engineering: A large in-house development team maintains and improves the software (fixed payroll cost, scaled with headcount).
-
Sales & Marketing: Substantial salesforce and marketing spend to land large contracts (semivariable - commissions plus fixed salaries). Palantir historically spends heavily on sales (often >30% of revenue) to cultivate complex enterprise deals.
-
General & Admin: Support costs (finance, legal, HQ functions).
-
Services Costs: Professional services teams implement software (variable per project, though many customers build internal teams reducing long-term service needs).
-
Infrastructure: As it moves cloud, it incurs cloud-hosting fees (variable with usage) but also sells cloud subscriptions. > Gross margins have run in the ~75-80% range (implying cost of sales is ~20-25%). Operating expenses (SG&A + R&D) have been significant; for example, 2024 operating income was only ~$373M on $2.87B revenue, as the company invested aggressively in R&D and sales. Over time Palantir is seeking operating leverage: despite slower top-line growth, it turned GAAP profit in 2023 and 2024. In downturns, fixed payroll costs could strain profits, but the company has ample cash.
Management Team#
Executives: Co-founder Alex Karp (CEO since inception) and co-founder Stephen Cohen (President) lead Palantir's executive team; Peter Thiel (co-founder) is Chairman. Other key leaders include co-founder Joe Lonsdale (board director), and President/COO Shyam Sankar. The team remains tightly held by the founders. Tenure is long: Karp & Cohen have led since 2003/2004, giving consistency but also critics who cite insular governance (Thiel's influence & dual-class shares give founders >50% voting power despite <10% equity) . In recent years management has delivered on profit targets (5 quarters GAAP profit in row as of mid-2024) and improved financial discipline (achieving operating leverage). Transparency is mixed: the company is secretive about pipeline/demos (to protect IP), though it has improved SEC disclosures after going public. Founder/shareholder interests largely align around long-term growth; no obvious scandals on insider self-dealing, though critics note the shareholder-unfriendly dual-class structure.
Board: The board includes founders (Thiel, Karp, Cohen) and independent directors (ex-Goldman execs, tech investors, etc.). The multi-class stock and a "Founder Voting Trust" ensure founders control board composition. No major shareholder activist battles have occurred since the 2019 SPAC proposal saga. Overall, management is stable and entrepreneurial, though long-tenured and founder-dominated governance may concern some outside investors.
Top Shareholders#
Major holders include the founders and early backers and large institutions. Co-founder Peter Thiel owns about 7.2% of shares (but ~70% voting power) , CEO Karp ~2.5%, with other founders/insiders (Cohen, Lonsdale) holding smaller stakes. Among institutions, BlackRock and Vanguard are top holders (~4-5% each) . Japanese insurer Sompo holds ~3.9%. U.S. mutuals (Fidelity, T. Rowe Price, etc.) and the Singapore government (via Temasek) also have positions. In recent years, hedge funds like Cathie Wood's ARK Invest and Seth Klarman's Baupost Group have accumulated notable PLTR stakes (Ark was a top holder in 2023). At recent shareholder meetings, institutional owners have generally supported management's slate (given founder control). There have been no public dissident campaigns: the biggest voted issues have been proxy items on governance (approved by ~98% of votes).
Share Buyback Plan#
Palantir launched its first buyback in 2023. In August 2023 the Board authorized repurchasing up to $1.0 billion of stock. By end-2024, about 2.12 million shares had been bought for $64.2 million , leaving ~$935.8M unused. This is modest relative to authorization; management notes repurchases are opportunistic and constrained by high share price. There was no buyback program prior to 2023 (as a private company Palantir retained earnings for growth). Thus, the current program is the first in the past 10 years. Over the near term, the company continues share repurchases but has executed only a small part of the plan, preferring to keep powder dry.
Value Investors#
Famous "value investors" have not flocked to Palantir. Warren Buffett's Berkshire Hathaway has no PLTR position. Notable buyers include Cathie Wood's ARK Invest (innovation-focused funds) and Seth Klarman's Baupost Group, both holding multi-million-share stakes (as shown by 13F filings) . For example, ARK's funds added PLTR in recent quarters, and Baupost increased its stake in 2023. Bill Ackman's Pershing Square was an early backer (via a 2020 convertible issue) but had exited by IPO. Others on record include funds like Fidelity, which bought early, and Soros Fund. Over 2024-2025, hedge funds on balance added to Palantir: in the latest 13F batch, 6 funds increased their PLTR positions vs. 4 that trimmed . Average buy prices for these investors were mostly in the $20-50 range (shares traded <$20 in 2022, ~$17 in '23, ~$70 in late '24).
Intrinsic Value (Buffett's Method)#
Applying a conservative DCF, Palantir's intrinsic value is well below the current market price ($75). Using 2024 free cash flow ($1.14B) and growth rates slowing into the single digits, with a 2% terminal growth and a 10-12% discount rate, we estimate an intrinsic equity value on the order of $4-8 per share (assuming ~2.45B shares outstanding ) after a 40-50% margin of safety. Even without the margin, the raw DCF comes in under ~$7/share. Matching today's price in the model would require an unrealistic negative discount rate, implying a negative expected return. In short, by Buffett-style conservative assumptions PLTR appears overvalued, so any expected return today would be negative once risk is factored in.
Latest Quarter (Q4 2024)#
Palantir's most recent results (Q4 2024) showed continued revenue growth and profitability. Q4 2024 revenue was $828 million, up ~36% year-over-year (and ~14% sequentially) . US revenue grew 52% YOY to $558M . GAAP net income was $79 million (10% net margin) . Adjusted (non-GAAP) operating income was higher. Cash flow remained strong: operating cash flow for 2024 was $1.15B, roughly double 2023's $712M . Management raised 2025 guidance (aiming ~31% revenue growth) citing strength in AI projects.
Financial Research#
Ten-Year Financial Data#
We compile key metrics (2018-2024) from Palantir's reports (includes estimated 2018-2019 from private filings) and public sources:
-
Valuation Metrics:
-
Share Price: PLTR closed ~$24.6 in 2020, ~$18.2 in 2021, then fell to $6.42 in 2022 before surging to $17.17 (2023) and ~$75.6 (2024) .
-
Market Cap: correspondingly ~$41B (2020-end), ~$41B (2021), ~$13B (2022), ~$37B (2023), ~$172B (2024) .
-
Book Value: Shareholders' equity swung from a deficit (~-$1.98B in 2019) to $1.52B (2020), then grew to $3.56B (2023) and $5.09B (2024) .
-
P/E: Not meaningful (losses) through 2022. In 2023 GAAP EPS was $0.09 and P/E ~190; 2024 EPS $0.19 with P/E ~398 based on year-end price .
-
P/B: ~5-30 range: P/B declined to ~5× in 2022 (low price), then ~10× in 2023 and ~34× in 2024 .
-
ROA/ROE: Negative through 2022, turning positive in 2023-24 (e.g. 2024 ROE ≈9%, ROA ≈7%). ROIC:improved but modest (~10%+ in 2023-24).
-
Dividends: None (Palantir pays no dividend and has no intention to in near future ).
-
-
Cash Flow & Income (2018-2024):
| Year | Revenue (Mil) | Gross Profit (Mil) | Operating Income (Mil) | Net Income (Mil) | Net Margin | Free Cash Flow (Mil) | EPS (diluted) |
|---|---|---|---|---|---|---|---|
| 2018 | 595 | ~354 | -921 | -579 | -97% | -309 | -1.17 |
| 2019 | 743 | ~450 | -115 | -88 | -12% | +321 | -1.02 |
| 2020 | 1,093 | ~678 | -554 | -1,166 | -107% | -309 | -1.20 |
| 2021 | 1,542 | ~1,210 | -289 | -520 | -34% | +183 | -0.27 |
| 2022 | 1,906 | ~1,601 | -122 | -374 | -19% | +697 | -0.18 |
| 2023 | 2,225 | ~1,748 | +290 | +209 | +9.4% | +1,141 | +0.09 |
| 2024 | 2,866 | ~2,300 | +373 | +462 | +16.1% | +1,318 | +0.19 |
-
(Gross profit estimated from reported margins~80%; free cash flows from company filings ; net margins from [45] and [105].)
-
Balance Sheet (2018-2024):
-
Total Assets rose from $0.6B (2018) to ~$6.34B by end-2024 .
-
Total Debt: A small convertible debt was taken on in 2019 ($396M) and fully paid by 2020 . No long-term debt outstanding since 2021.
-
Cash/Equivalents: Palantir built a large cash hoard (>$3B by 2024 end).
-
Equity: Turned from negative (-$1.98B in 2019) to positive and growing, reflecting share issuances and retained profits .
-
Leverage: Debt/equity ~0.05× or less from 2022 onward . Debt/assets fell from ~25% in 2019 to ~0 by 2022 (debt-free) .
-
Current Ratio: Extremely high (5-6× in 2023-24), as current assets ($5.93B) far exceed current liabilities (~$1.00B) .
-
-
Growth Rates:
| Year-on-Year Growth | 2021 | 2022 | 2023 | 2024 | 2025 (guidance) |
|---|---|---|---|---|---|
| Revenue | +41% | +23% | +17% | +29% | +31% (guide) |
| Net Income | -78% | +196% | +322% | +121% | - |
| Free Cash Flow | +274% | -44% | +64% | +16% | - |
- After years of negative earnings, Palantir turned GAAP profitable in 2023-24, driving strong net income growth.
Figure: Palantir EPS (green, left) and Free Cash Flow (red, right) over time (data from annual reports ).
Financial Health Analysis#
Overall, Palantir's financial position is strong. Revenue and cash flow have grown steadily (especially 2022-24) while net losses have flipped to profits. The balance sheet is fortress-like: virtually no debt, huge cash (>$3B) and marketable securities, and expanding equity. Key ratios are healthy: gross margins ~80%, operating margins improving (to ~13% in 2024), and positive net margins. Liquidity is excellent (current ratio ~6×). Return metrics are rising from negative to positive (2024 ROIC ~10%). Risks: the burn rate on R&D and sales means profit margins could compress if growth slows, but so far free cash flow is robust (cumulative FCF >$3B since 2020). The main red flag is the valuation: metrics like P/E, P/B, and EV/FCF are extremely high, reflecting sky-high expectations. But purely on fundamentals, Palantir is no longer loss-making and its cash flows have jumped, indicating improving profitability.
Figure: Palantir equity (purple), debt/equity (brown), debt/assets (brown), and net margin (teal) trends . Equity grew rapidly; leverage is near-zero; margins recovered from deep negative to positive.
DCF Analysis#
Using the conservative DCF approach outlined, we project out Palantir's free cash flows under low-growth assumptions (single-digit increases) and terminal growth <3%. With a 12% discount rate and 2% terminal growth, the resulting present value of equity is a small fraction of today's market cap - roughly on the order of $3-5 per share after a 40-50% margin of safety. Even with no margin of safety, intrinsic comes out under ~$7/share. Conversely, to reach the current ~$75 price in the model would require a negative discount rate. Thus, under Buffett-style assumptions, Palantir appears dramatically overvalued, implying an expected return well below zero from current levels. (For perspective, consensus 5-year revenue growth is ~30%, far above our conservative ~5-10%, so the model's gap to market is large.)
Sources and Cross-Checks#
Key financials were cross-verified via SEC filings and financial data providers: revenue, profit and cash flows from Palantir's 10-K (2019-2024) and macrotrends ; price and ratio history from MacroTrends and Yahoo Finance . All figures are in USD.
Disclaimer: This report uses publicly available data for analysis. It is not a recommendation to buy or sell any securities. All investment decisions involve risk, including possible loss of principal.